SARS-CoV-2 Spike Protein RBD (Delta B.1.617.2 Variant) from ABBEXA LTD
Search, find, compare suppliers for SARS-CoV-2 Spike Protein RBD (Delta B.1.617.2 Variant) products.
| Edit | |
|---|---|
| Product Name | SARS-CoV-2 Spike Protein RBD (Delta B.1.617.2 Variant) |
| Description | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Spike Protein Receptor-Binding Domain (RBD) is a recombinant protein expressed in Insect cells. The SARS-CoV-2 Spike Protein (S protein) is a viral protein that allows the entry of SARS-CoV-2 into human cells. The protein forms trimers on the viral capsid and binds to human Angiotensin Converting Enzyme 2 (ACE2) located on the cell surface. The protein has a cleavage site between the Spike Protein and S2 subunits that is targeted by the human enzyme Furin, and it may also cause the development of a syncytium (cell fusion). Antibodies to S protein can prevent viral entry as well as target the virus for further immune action. The B.1.617.2 (Delta) variant was first identified in India. It contains the L452R and T478K mutations, which appear to increase viral infectivity compared with other variants. His tag. Purity ≥ 90% (SDS-PAGE). Calculated MW: 26 kDa Observed MW (12% reducing SDS-PAGE): 28 kDa. Difference is due to glycosylation. |
| Size | 1 mg |
| Concentration | 3.9 mg/ml |
| Applications | ELISA, WB |
| Other Names | Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV-2, COVID-19, 2019-nCoV, 2019 novel coronavirus, COVID19, SARS-CoV-2 Spike S1 (RBD), SARS-CoV-2 Spike S1 RBD (Receptor-Binding Domain) Protein, SARS-CoV-2 Spike Protein RBD (India B.1.617.2 Variant), SARS-CoV-2 Spike Protein RBD (B.1.617.2 India Variant), SARS-CoV-2 Spike Protein RBD (B.1.617.2 Indian Variant), SARS-CoV-2 S1 Protein RBD L452R and T478K Mutations, SARS-CoV-2 Spike Protein RBD (Delta B.1.617.2 Variant), SARS-CoV-2 Spike Protein RBD (Delta Variant), Severe Acute Respiratory Syndrome Coronavirus 2 protein, Protein Severe Acute Respiratory Syndrome Coronavirus 2, Virus Severe Acute Respiratory Syndrome Coronavirus 2 Protein, Virus Severe Acute Respiratory Syndrome Coronavirus 2, Virus protein Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV-2 protein, Protein SARS-CoV-2, Virus SARS-CoV-2 Protein, Virus SARS-CoV-2, Virus protein SARS-CoV-2, COVID-19 protein, Protein COVID-19, Virus COVID-19 Protein, Virus COVID-19, Virus protein COVID-19, 2019-nCoV protein, Protein 2019-nCoV, Virus 2019-nCoV Protein, Virus 2019-nCoV, Virus protein 2019-nCoV, 2019 novel coronavirus protein, Protein 2019 novel coronavirus, Virus 2019 novel coronavirus Protein, Virus 2019 novel coronavirus, Virus protein 2019 novel coronavirus, COVID19 protein, Protein COVID19, Virus COVID19 Protein, Virus COVID19, Virus protein COVID19, SARS-CoV-2 Spike S1 (RBD) protein, Protein SARS-CoV-2 Spike S1 (RBD), Virus SARS-CoV-2 Spike S1 (RBD) Protein, Virus SARS-CoV-2 Spike S1 (RBD), Virus protein SARS-CoV-2 Spike S1 (RBD), SARS-CoV-2 Spike S1 RBD (Receptor-Binding Domain) Protein protein, Protein SARS-CoV-2 Spike S1 RBD (Receptor-Binding Domain) Protein, Virus SARS-CoV-2 Spike S1 RBD (Receptor-Binding Domain) Protein Protein, Virus SARS-CoV-2 Spike S1 RBD (Receptor-Binding Domain) Protein, Virus protein SARS-CoV-2 Spike S1 RBD (Receptor-Binding Domain) Protein, SARS-CoV-2 Spike Protein RBD (India B.1.617.2 Variant) protein, Protein SARS-CoV-2 Spike Protein RBD (India B.1.617.2 Variant), Virus SARS-CoV-2 Spike Protein RBD (India B.1.617.2 Variant) Protein, Virus SARS-CoV-2 Spike Protein RBD (India B.1.617.2 Variant), Virus protein SARS-CoV-2 Spike Protein RBD (India B.1.617.2 Variant), SARS-CoV-2 Spike Protein RBD (B.1.617.2 India Variant) protein, Protein SARS-CoV-2 Spike Protein RBD (B.1.617.2 India Variant), Virus SARS-CoV-2 Spike Protein RBD (B.1.617.2 India Variant) Protein, Virus SARS-CoV-2 Spike Protein RBD (B.1.617.2 India Variant), Virus protein SARS-CoV-2 Spike Protein RBD (B.1.617.2 India Variant), SARS-CoV-2 Spike Protein RBD (B.1.617.2 Indian Variant) protein, Protein SARS-CoV-2 Spike Protein RBD (B.1.617.2 Indian Variant), Virus SARS-CoV-2 Spike Protein RBD (B.1.617.2 Indian Variant) Protein, Virus SARS-CoV-2 Spike Protein RBD (B.1.617.2 Indian Variant), Virus protein SARS-CoV-2 Spike Protein RBD (B.1.617.2 Indian Variant), SARS-CoV-2 S1 Protein RBD L452R and T478K Mutations protein, Protein SARS-CoV-2 S1 Protein RBD L452R and T478K Mutations, Virus SARS-CoV-2 S1 Protein RBD L452R and T478K Mutations Protein, Virus SARS-CoV-2 S1 Protein RBD L452R and T478K Mutations, Virus protein SARS-CoV-2 S1 Protein RBD L452R and T478K Mutations, SARS-CoV-2 Spike Protein RBD (Delta B.1.617.2 Variant) protein, Protein SARS-CoV-2 Spike Protein RBD (Delta B.1.617.2 Variant), Virus SARS-CoV-2 Spike Protein RBD (Delta B.1.617.2 Variant) Protein, Virus SARS-CoV-2 Spike Protein RBD (Delta B.1.617.2 Variant), Virus protein SARS-CoV-2 Spike Protein RBD (Delta B.1.617.2 Variant), SARS-CoV-2 Spike Protein RBD (Delta Variant) protein, Protein SARS-CoV-2 Spike Protein RBD (Delta Variant), Virus SARS-CoV-2 Spike Protein RBD (Delta Variant) Protein, Virus SARS-CoV-2 Spike Protein RBD (Delta Variant), Virus protein SARS-CoV-2 Spike Protein RBD (Delta Variant) |
| Gene, Accession, CAS # | n/a |
| Catalog # | abx160090 |
| Price | please inquire |
| Order / More Info | SARS-CoV-2 Spike Protein RBD (Delta B.1.617.2 Variant) from ABBEXA LTD |
| Product Specific References | n/a |
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950
Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com
https://www.abbexa.com
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950
Profile of ABBEXA LTD
Return to Products